Noninvasive prenatal diagnosis of trisomy 21, 18 and 13 using cell - free fetal DNA;Nieinwazyjna diagnostyka prenatalna trisomii 21, 18 i 13 z wykorzystaniem wolnego pozakomórkowego DNA płodu

Ginekologia Polska

Volumn 84, Issue 8, 2013, Pages 714-719

  Gorzelnik, Katarzyna ^a   Bijok, Julia ^a   Zimowski, Janusz G ^b   Jakiel, Grzegorz ^a   Roszkowski, Tomasz ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

CffDNA; Chromosomal aneuploidies; Massively parallel sequencing; Maternal blond; Noninvasive prenatal diagnosis

Indexed keywords

EID: 84885349867     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Driscoll D, Gross S. Clinical practice. Prenatal screening for aneuploidy. N Eng J Med. 2009, 360, 2556-2562.
2. Snijders R, Holzgreve W, Cuckle H, Nicolaides K. Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenat Diagn. 1994, 14, 543-552.
3. Kagan K, Staboulidou I, Cruz J, [et al.]. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol. 2010, 36, 542- 547.
4. Nicolaides KH. Screening for fetal aneuploides at 11 to 13 weeks. Prenat Diagn. 2011, 31, 7-15.
5. Rekomendacje Zespolu Ekspertów PTG. Rekomendacje Polskiego Towarzystwa Ginekologicznego dotyczace postepowania w zakresie diagnostyki prenatalnej. Ginekol Pol. 2009, 80, 390-393.
6. Corrado F, Cannata M, La Galia T, [et al.]. Pregnancy outcome following mid-trimester amniocentesis. J Obstet Gynaecol. 2012, 32, 117-119.
7. Mujenovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villus sampling. Obstet Gynecol. 2007, 110, 687-694.
8. Chitty L, Hill M, White H, [et al.]. Noninvasive prenatal testing for aneuploidy-ready for prime time? Am J Obstet Gynecol. 2012, 206, 269-275.
9. Walknowska J, Conte F, Grumbach M. Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet 1969, 1, 1119-1122.
10. Bianchi D, Simpson J, Jackson L, [et al.]. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. Prenat Diagn. 2002, 22, 609-615.
11. Lepez T, Vandewostyne M, Hussain S, [et al.]. Fetal microchimetric cells in blond of women with an autoimmune thyroid disease. PLoS One. 2011, 6, e29646.
12. Pearson H. Life-span of fetal red blood cell. J Pediatr 1967, 70, 166-171.
13. Bianchi D, Zickwolf G, Weil G, [et al.].. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996, 93, 705-708.
14. Bianchi D, Williams J, Sullivan L, [et al.]. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet. 1997, 61, 822-829.
15. Choolani M. The promise of fetal cells in maternal blood. B Pract Res Clin Obstet Gynecol. 2012, 26, 655-667.
16. Lo YM, Corbetta N, Chamberlain P, [et al.]. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997, 350, 485-487.
17. Hui L, Bianchi D. Recent advances in the prenatal interrogation of the human fetal genome. Trends Genet. 2013, 29, 84-91.
18. Bianchi D. Circulating fetal DNA: its origin and diagnostics potential-a review. Placenta. 2004, 25, Suppl. A, S93-S101.
19. Norton M, Brar H, Weiss J, [et al.]. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study or detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012, 207, 137.e1-8.
20. Lo Y. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998, 62, 768-775.
21. Lo YMD, Zhang J, Leung TN, [et al.]. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999, 64, 218-224.
22. Rijnders R, Christiaens G, Soussan A, van der Schoot C. Cell-free fetal DNA is not present in plasma of nonpregnant mothers. Clin Chem. 2004, 50, 697-681.
23. Invernizzi P, Biondi M, Battezzati P, [et al.]. Presence of fetal DNA in maternal plasma decades after pregnancy. Hum Genet. 2002, 110, 587-591.
24. Chiu R, Poon L, Leung T, [et al.]. Effects of blood-processing protocols on fetal ant total DNA quantification in Maternal plasma. Clin Chem. 2001, 47, 1607-1613.
25. Lo Y, Leung T, Tein M, [et al.]. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999, 45, 184-188.
26. Lau T, Leung T, Chan L, [et al.]. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem. 2002, 48, 2141-2146.
27. Orzinska A, Guz K, Brojer E Nieinwazyjne badania prenatalne z osocza kobiet ciezarnych w konflikcie serologicznym w Polsce. Ginekol Pol. 2009, 80, 768-771.
28. Rijnders R, Schoot van der E, Bossers B, [et al.]. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol. 2001, 98, 374-378.
29. Finning K, Martin P, Daniels G. The use of maternal plasma for prenatal RhD blood group genotyping. Methods Mol Biol. 2009, 496, 143-157.
30. Leung T, Zhang J, Lau T, [et al.]. Increased Maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem. 2001, 47, 137-139.
31. Leung T, Zhang J, Lau T, [et al.]. Maternal plasma fetal DNA as a maker for preterm labour. Lancet. 1998, 352, 1904-1905.
32. Amicucci P, Gennarelli M, Novelli G, [et al.]. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem. 2000, 46, 301-302.
33. Saito H, Sekizawa A, Morimoto T, [et al.]. Prenatal DNA diagnosis of single gene disorder from maternal plasma. Lancet. 2000, 356, 1170.
34. Houfflin-Debarge V, O'Donnell H, Overton T, [et al.]. High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood. Fetal Diagn Ther. 2000, 15, 102-107.
35. Li Y, Di Naro E, Vitucci A, [et al.]. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA. 2005, 293, 843-849.
36. Fan H, Quake S. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem. 2007, 79, 7576-7579.
37. Lo Y, Lun F, Chan K, [et al.]. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA. 2007, 104, 13116-13121.
38. Rossa W, Chiu K, Allen Chan, [et al.]. Noninvasive Prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma Proc Natl Acad Sci USA. 2008, 105, 20458-20463.
39. Lo Y, Lun F, Chan K, [et al.]. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA. 2007, 104, 13116-13121.
40. Fan H, Blumenfeld Y, Chitkara U, [et al.]. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA. 2008, 105, 16266-16271.
41. Ashoor G, Syngelaki A, Wang E, [et al.]. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol. 2013, 41, 21-25.
42. Chen E, Chiu R, Sun H, [et al.]. Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing. PLoS ONE. 2011, 6, e21791.
43. Liang D, Lv W, Wang H, [et al.]. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn. 2013, 32, 1225-1232.
44. Verweij E, van den Oever J, de Boer M, [et al.]. Diagnostic Accuracy of Noninvasive Detection of Fetal Trisomy 21 in Maternal Blood: A Systematic Review. Fetal Diagn Ther. 2012, 31, 81-86.
45. Dan S, Wang W, Ren J, [et al.]. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors. Prenat Diagn. 2012, 9, 1-8.
46. Ashoor G, Syngelaki A, Wagner M, [et al.]. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012, 206, 322.e1-5.
47. Palomaki G, Deciu C, Kloza E, [et al.]. DNA sequencing of maternal plasma reliably identiies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 2012, 14, 296-305.
48. Ashoor A, Syngelaki A, Wang E, [et al.]. Trisomy 13 detection in the first trimester of pregnancy using a chromosome - selective cell - freee DNA analysis method. Ultrasound Obstet Gynecol. 2013, 41, 21-25.
49. Nicolaides K, Syngelaki A, Ashoor G, [et al.]. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol. 2012, 207, 374.e1-6.
50. Brar H, Wang E, Struble C, [et al.]. The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy. J Matern Fetal Neonatal Med. 2013, 26, 143-145.
51. Hui L. Non-invasive prenatal testing for fetal aneuploidy: charting the course from clinical validity to clinical utility. Ultrasound Obstet Gynecol. 2013, 41, 2-6.
52. Verweij E, de Boer M, Oepkes D. Non-invasive prenatal diagnosis for Down syndrome: no paradigm shift, just better testing and it is already here! Ultrasound Obstet Gynecol. 2012, 40, 484-485.
53. Benn P, Cuckle H, Pergament E. Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly. Ultrasound Obstet Gynecol. 2012, 39, 127-130.
54. Tabor A, Vestergaard C, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol. 2009, 34, 19-24.
55. Bijok J, Szyszka M, Michalowska A, Roszkowski T[et al.]. Analiza biopsji trofoblastu przeprowadzonych w I Klinice Ginekologii i Poloznictwa - CMKP SPSK im. Prof. Orlowskiego w Warszawie - doniesienie wstepne. Perinatologia, Neonatologia i Ginekologia. 2010, 3, 145-152.
56. Silver R, Blum K, Geibel L, [et al.]. Clinical implications of atypical chromosome abnormalities diagnosed prenatally. Obstet Gynecol. 1999, 94, 925-928.
57. http://lifecodexx.com/yourcontactpersons0.html
58. Devers P, Cronister A, Ormond K, [et al.]. Noninvasive Prenatal Testing/Noninvasive Prenatal Diagnosis: the Position of the National Society of Genetic Counselors. J Genet Couns. 2013, 22, 291-295.
59. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012, 120, 1532-1534.